We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
351
FedEx
FDX
$73.2B
$353K ﹤0.01%
1,413
+12
+0.9% +$2.74K
SYF icon
352
Synchrony
SYF
$25.3B
$338K ﹤0.01%
8,757
– –
HOMB icon
353
Home BancShares
HOMB
$6.27B
$327K ﹤0.01%
14,046
+1,229
+10% +$28.7K
LAND
354
Gladstone Land Corp
LAND
$348M
$327K ﹤0.01%
24,375
+100
+0.4% +$1.35K
ETP
355
DELISTED
Energy Transfer Partners, L.P.
ETP
$319K ﹤0.01%
17,800
– –
ICF icon
356
iShares Select U.S. REIT ETF
ICF
$2.1B
$318K ﹤0.01%
6,272
– –
SCHW
357
Charles Schwab
SCHW
$184B
$318K ﹤0.01%
6,196
+38
+0.6% +$1.78K
HIW icon
358
Highwoods Properties
HIW
$3.67B
$316K ﹤0.01%
6,200
– –
KUB
359
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$314K ﹤0.01%
3,180
– –
AMAT icon
360
Applied Materials
AMAT
$411B
$311K ﹤0.01%
6,080
+430
+8% +$23.3K
PID icon
361
Invesco International Dividend Achievers ETF
PID
$923M
$305K ﹤0.01%
18,430
+150
+0.8% +$2.41K
VSS icon
362
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
$305K ﹤0.01%
2,560
-90
-3% -$10.5K
RYN icon
363
Rayonier
RYN
$6.48B
$301K ﹤0.01%
10,498
– –
BIIB icon
364
Biogen
BIIB
$29.8B
$295K ﹤0.01%
925
-32
-3% -$10.3K
ELV icon
365
Elevance Health
ELV
$83B
$294K ﹤0.01%
1,306
– –
TGT icon
366
Target
TGT
$67.8B
$290K ﹤0.01%
4,453
+53
+1% +$3.2K
EPD icon
367
Enterprise Products Partners
EPD
$81.9B
$283K ﹤0.01%
10,694
– –
LCNB icon
368
LCNB Corp
LCNB
$282M
$280K ﹤0.01%
13,673
– –
FBIN icon
369
Fortune Brands Innovations
FBIN
$6.22B
$262K ﹤0.01%
4,482
-30
-0.7% -$1.7K
SMFG icon
370
Sumitomo Mitsui Financial
SMFG
$160B
$259K ﹤0.01%
29,845
– –
CMI icon
371
Cummins
CMI
$89.5B
$247K ﹤0.01%
1,401
-7
-0.5% -$1.2K
CELG
372
DELISTED
Celgene Corp
CELG
$246K ﹤0.01%
2,360
– –
QCOM icon
373
Qualcomm
QCOM
$159B
$245K ﹤0.01%
+3,837
New +$233K
MHK icon
374
Mohawk Industries
MHK
$9.01B
$243K ﹤0.01%
882
– –
IWB icon
375
iShares Russell 1000 ETF
IWB
$49B
$224K ﹤0.01%
+1,509
New +$219K
13 14
15
16 17

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.